<p>Capecitabine is a nucleoside metabolic inhibitor with antineoplastic activity indicated for:</p>

<ul>
	<li><strong>Adjuvant Colon Cancer</strong>: Patients with Dukes&#39;C colon cancer.</li>
	<li><strong>Metastatic Colorectal Cancer</strong>: First-line as monotherapy when treatment with fluoropyrimidine therapy alone is preferred.</li>
	<li><strong>Metastatic Breast Cancer</strong>: In combination with docetaxel after failure of prior anthracycline containing therapy.</li>
	<li>As monotherapy in patients resistant to both paclitaxel and an anthracycline-containing regimen.</li>
</ul>